Desensitization Strategies in Immunized Heart Transplant Recipients
Crossing the HLA barrier is feasible and safe in heart transplantation. The complexity and redundancy of the immune pathways requires the identification of the appropriate therapy for each patient. Desensitization protocols should include more than one drug and intervention.
Authors
- K. Aburahma (ORCID: https://orcid.org/0009-0006-5507-2003)
- F. Ius (ORCID: https://orcid.org/0000-0002-8084-3360)
- A. Goerler
- J. Salman (ORCID: https://orcid.org/0000-0002-7172-2946)
- Nunzio Davide de Manna (ORCID: https://orcid.org/0000-0002-1319-8146)
- Bastian Schmack (ORCID: https://orcid.org/0009-0001-5594-0580)
- S. Kruszona
- M. Avşar (ORCID: https://orcid.org/0000-0002-1146-2484)
- Arjang Ruhparwar
Institutions
- Medizinische Hochschule Hannover (DE)
- German Center for Lung Research (DE)
Publication Details
- Journal
- European Surgical Research
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1159/000549669
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00